Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Healthcare Professionals
Healthcare Professionals Healthcare Professionals

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Healthcare Conferences &
Educational Opportunities






Oct. 8 - 11

Skin, Bones, Hearts & Private Parts 2019 San Antonio CME/CE Conference

Skin, Bones, Hearts & Private Parts

Oct. 17 - 20

AASPA 19th CME Meeting & Surgical Update

American Association of Surgical Physician Assistants

Oct. 20 - 27

Skin, Bones, Hearts & Private Parts 2019 Caribbean Cruise CME/CE Conference

Skin, Bones, Hearts & Private Parts

Oct. 21 - 24

Skin, Bones, Hearts & Private Parts 2019 Orlando CME/CE Conference

Skin, Bones, Hearts & Private Parts

Oct. 31 - Nov. 2

National Student Conclave (NSC)

American Physical Therapy Association

More Events

Faculty Investigate Safety Of Suboxone Use In Pregnant, Opioid-Dependent Women | NEWS-Line for Healthcare Professionals

Faculty Investigate Safety Of Suboxone Use In Pregnant, Opioid-Dependent Women


Source:

Medications that physicians have traditionally prescribed to treat opioid use disorders—such as methadone and Subutex—can be misused by taking them in larger amounts than prescribed or by injecting them.

The medication Suboxone is different.

A combination of buprenorphine and naloxone, Suboxone helps to prevent relapses by blocking the effect of the opioids.

“The naloxone discourages misuse as it is activated if an individual attempts to inject the medication,” said Laura Lander, West Virginia University Social Work Section Chief and associate professor in the WVU School of Medicine.

And that activation isn’t pleasant.

“Misuse of this medication could make you start to feel sick, or even go into withdrawal,” explained Patrick Marshalek, a psychiatrist and clinical associate professor in WVU’s School of Medicine and the medical director of WVU’s Chestnut Ridge Center.

In a recent project, he and Lander examined the medical records of 26 pregnant women who were prescribed Suboxone to treat their opioid use disorder.

All of the women participated in the Chestnut Ridge Center’s Comprehensive Opioid Addiction Treatment program.

Marshalek and Lander also reviewed the medical records of the women’s newborn babies. The researchers looked at the newborns’ gestational age; weight, length and head circumference; Apgar score; duration of hospital stay; diagnosis of neonatal opioid withdrawal syndrome; and prescribed pharmacological treatment for withdrawal.

They found that babies exposed to Suboxone in utero fared as well as, or better than babies exposed to more conventional addiction treatments, such as treatment with methadone or Subutex.

“It used to be, if you were pregnant, you would be prescribed methadone,” said Lander, who is also an addiction therapist at Chestnut Ridge Center.

Clinicians didn’t put Subutex into common use for treating pregnant, opioid-dependent women until a landmark study in 2010 by Hendree Jones, a co-researcher on the current project, indicated that babies whose mothers took Subutex while pregnant had a lower incidence of withdrawal. If they did have withdrawal, it tended to be milder and required a shorter hospital stay.

Now Lander and Marshalek hope their findings, published in the “American Journal on Addictions,” will make clinicians feel more comfortable prescribing Suboxone to their pregnant patients in treatment.

In the future, a randomized clinical trial would be conducted to explore how Suboxone and Subutex affect babies over the long term, even into childhood. In the meantime, Lander and Marshalek are training healthcare practitioners across West Virginia to pharmacologically treat opioid dependence. These patients include opioid-dependent pregnant women, whom Lander called “the most stigmatized folks,” even by their own peers with substance use disorders.

Lander and Marshalek’s research indicates that Suboxone may be a safe option for helping these stigmatized women who, as Marshalek said, already “face additional barriers to care.”

[photo credit: West Virginia University]







Share This!


Healthcare Jobs








CMA, RMA, LPN, RN

Gateway Medical Associates
Exton, PA

Neonatal Nurse Practitioner - Clinical Instructor

Stony Brook University
Stony Brook, NY

Clinical Coordinator/Faculty - Physician Assistant Program

Gannon University
Ruskin, Florida

RN/LPN

Parsons State Hospital & Training Center
Parsons, KS

Psychologist/Public Service Executive

Parsons State Hospital & Training Center
Parsons, KS

MT or MLT

American Pathology Partners|UniPath
Durango, Colorado

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.